Paradigm Biopharmaceuticals Ltd.ASX: PAR

Further Agreed Convertible Note Redemption

· Issued by Paradigm Biopharmaceuticals Ltd. via ASX

Filed with ASX · · 1 page · English

Summary by 6ix AI

Paradigm Biopharmaceuticals Ltd. reports the redemption and cancellation of additional convertible notes following an agreement with Obsidian Global GP, LLC. This action is part of a broader agreement secured by the company's assets.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/further-agreed-convertible-note-redemption

Release

ASX RELEASE 22 October 2026 Further Obsidian Note Redemption Paradigm Biopharmaceuticals Limited (Administrators Appointed) (ASX: PAR) ("Paradigm" or "the Company") advises that, following discussions with Obsidian Global GP, LLC ("Obsidian"), the parties have agreed to the redemption and...

Paradigm Biopharmaceuticals Ltd. on 6ix

Earlier from Paradigm Biopharmaceuticals

Later from Paradigm Biopharmaceuticals

All Paradigm Biopharmaceuticals news releases